Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · IEX Real-Time Price · USD
2.270
+0.030 (1.34%)
At close: Mar 28, 2024, 4:00 PM
2.260
-0.010 (-0.44%)
After-hours: Mar 28, 2024, 6:12 PM EDT

Carisma Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2011
Net Income
-19.88-0.34-22.54-107.5-33.69-29.031.89-33.45-34.68-21.88
Upgrade
Depreciation & Amortization
0.010.090.120.220.210.290.180.370.410.44
Upgrade
Share-Based Compensation
6.915.141.761.241.281.384.012.532.431.26
Upgrade
Other Operating Activities
37.86-73.77-10.3268.529.379.6-3.54-3.972.012.83
Upgrade
Operating Cash Flow
24.9-68.88-30.84-37.52-22.83-17.772.54-34.53-29.31-13.49
Upgrade
Capital Expenditures
0.03-0-0.01-0.14-00.10.33-0.29-0.140
Upgrade
Acquisitions
0000000.14000
Upgrade
Change in Investments
-54000000000
Upgrade
Investing Cash Flow
-53.97-0-0.01-0.14-00.10.46-0.29-0.140
Upgrade
Share Issuance / Repurchase
0176.1338.135.3558.587.010.2712.7170.310.03
Upgrade
Debt Issued / Paid
000000-14.124.125.255.99
Upgrade
Other Financing Activities
--00.010.01--0.04--7.53
Upgrade
Financing Cash Flow
0176.1338.1135.3658.587.01-13.8216.8475.5613.55
Upgrade
Net Cash Flow
-29.07107.257.27-2.335.75-10.66-10.82-17.9846.120.06
Upgrade
Free Cash Flow
24.93-68.88-30.85-37.66-22.83-17.672.86-34.82-29.44-13.49
Upgrade
Free Cash Flow Margin
62.31%-259.50%-274.52%---4156.94%9.55%-3516.77%-1312.71%-1011.54%
Upgrade
Free Cash Flow Per Share
2.49-7.56-5.22-8.28-7.39-13.542.72-36.66-40.21-199.62
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).